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Abstract
Potential biological roles of the Campylobacter jejuni genes  cj0641, cj0774c and  cj1663  were
investigated. The proteins encoded by these genes showed sequence similarities to the
phosphonate utilisation PhnH, K and L gene products of Escherichia coli. The genes cj0641, cj0774c
and cj1663 were amplified from the pathogenic C. jejuni strain 81116, sequenced, and cloned into
pGEM-T Easy vectors. Recombinant plasmids were used to disrupt each one of the genes by
inserting a kanamycin resistance (KmR) cassette employing site-directed mutagenesis or inverse
PCR. Campylobacter jejuni 81116 isogenic mutants were generated by integration of the mutated
genes into the genome of the wild-type strain. The C. jejuni mutants grew on primary isolation
plates, but they could not be purified by subsequent passages owing to cell death. The mutant C.
jejuni strains survived and proliferated in co-cultures with wild-type bacteria or in media in which
wild-type C. jejuni had been previously grown. PCR analyses of mixed wild-type/mutant cultures
served to verify the presence of the mutated gene in the genome of a fraction of the total bacterial
population. The data suggested that each mutation inactivated a gene essential for survival. Rates
of phosphonate catabolism in lysates of E. coli strain DH5α were determined using proton nuclear
magnetic resonance spectroscopy. Whole-cell lysates of the wild-type degraded
phosphonoacetate, phenylphosphonate and aminomethylphosphonate. Significant differences in the
rates of phosphonate degradation were observed between lysates of wild-type E. coli, and of
bacteria transformed with each one of the vectors carrying one of the C. jejuni genes, suggesting
that these genes were involved in phosphonate catabolism.
Background
Phosphorus is an essential element for living organisms.
In bacteria it has roles in biosynthesis and energy metab-
olism, as well as in the structure of biomolecules. Phos-
phonates (Phn) are a class of organophosphates
structurally similar to phosphate esters, but characterised
by a carbon-to-phosphorus (C-P) bond [1-3]. The C-P
bond is highly stable compared to oxygen-to-phosphorus,
nitrogen-to-phosphorus or sulphur-to-phosphorus
bonds. The C-P bond is resistant to chemical hydrolysis,
thermal decomposition, photolysis [4], and to the action
of phosphatases [5,6]. During phosphate limitation stress,
Published: 25 June 2009
Gut Pathogens 2009, 1:13 doi:10.1186/1757-4749-1-13
Received: 7 May 2009
Accepted: 25 June 2009
This article is available from: http://www.gutpathogens.com/content/1/1/13
© 2009 Hartley et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Gut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
Page 2 of 9
(page number not for citation purposes)
some bacteria can utilise phosphonates as an alternative
source of phosphorus by breaking the C-P bonds of these
compounds [7-9].
Four routes of phosphonate catabolism are known in
microorganisms, namely, the phosphonoacetaldehyde
hydrolase (phosphonatase), phosphonoacetate hydro-
lase, phosphonopyruvate hydrolase and C-P lyase path-
ways [6,10]. Cleavage mechanisms and substrate
specificity are different for each pathway. C-P lyase path-
ways are able to cleave a variety of phosphonates includ-
ing aminomethylphosphonate (AmePhn) and
phenylphosphonate (PhePhn), the latter is not degraded
by other enzymes of phosphonate catabolism [1,11-13].
Genes encoding C-P lyase pathways have been found in
bacteria of the genera Enterobacter, Escherichia, Klebsiella
and Kluyvera [1,11-14]; and phosphonatase pathways are
found in the genera Enterobacter and Salmonella [11,15].
Recently, it was demonstrated that Campylobacter spp. are
capable of degrading some phosphonate-bearing com-
pounds although in silico analyses indicated that no genes
orthologous to those encoding C-P bond-cleaving
enzymes in other bacteria are present in the genome of
Campylobacter jejuni [12]. Two different C-P bond cleavage
activities were discovered in Campylobacter spp. The first
one is associated with the cell wall and has the ability to
catalyse phenylphosphonate and phenylphosphinate
(PhePhi). The second cleavage activity is found in both
the cell wall and cytosolic fractions and catalyses
phosphonoalkyl carboxylates [12]. Phosphonate metabo-
lism in Campylobacter does not require phosphate starva-
tion conditions, unlike other bacteria in which the
expression of Phn-degrading enzymes are under control
of the Pho regulon [7,13,16].
The molecular basis of Phn catabolism by C. jejuni wasin-
vestigated in this study. In silico analyses were performed
to identify C. jejuni genes encoding proteins with similar-
ity to those involved in C-P bond hydrolysis in E. coli K12
[8]. Isogenic mutants of wild-type C. jejuni strain 81116
were constructed by disrupting with a kanamycin cassette
three genes encoding proteins potentially implicated in
phosphonate degradation, and the viability of the
mutants was determined. Mutants of E. coli DH5α were
generated by transforming the wild-type strain with plas-
mids carrying each one of the C. jejuni genes putatively
involved in Phn catabolism. The rates of degradation of
three phosphonate compounds by the mutant E. coli were
compared to those of the wild-type.
Results
In silico analyses of genes putatively involved in 
phosphonate catabolism
Three genes orthologous to those involved in C-P bond
cleavage in E. coli were identified in the genome of C.
jejuni strain NCTC 11168 by protein homology analyses.
The proteins encoded by the C. jejuni genes, cj0774c and
cj1663 showed homology to the E. coli membrane-associ-
ated C-P lyase proteins PhnK and PhnL encoded by the
phnC-P operon (Table 1). Domain architecture searches
demonstrated that the four proteins contained the
ABC_MJ0796 domain characteristic of some ATP-binding
cassettes of ABC transport systems. The protein encoded
by cj0641 showed low similarity to E. coli PhnH, but had
48% similarity to the inorganic polyphosphate/ATP-NAD
kinase JHP1433 of H. pylori strain J99 an enzyme which
utilizes ATP and other nucleoside triphosphates as well as
inorganic polyphosphate as a source of phosphorus, and
contains a COG3221.2 domain of the periplasmic com-
ponent of ABC-type/phosphonate transport system. In
comparison, the similarities of E. coli PhnH, PhnK and
PhnL with proteins of the C-P lyase pathway of Entero-
bacter sp. 638 were 92, 98 and 92%, respectively; and the
similarities with Klebsiella pneumoniae proteins were 90,
97 and 90%, respectively.
Investigation of the genomic organisation of the genes
cj0641, cj0774c and cj1663 indicated that they were not
co-located, and none of the genes appeared to be co-tran-
scribed with other genes.
Isolation of Campylobacter jejuni genes
The three coding regions cj0641, cj0774c and cj1663 were
amplified from C. jejuni strain 81116 and cloned into the
vector pGEM-T Easy by standard cloning techniques. The
primers used for the amplification of these genes given in
Table 2 were designed based on the published nucleotide
sequence of C. jejuni NCTC 11168 [17]. Sequence analy-
ses of the genes cloned into the recombinant plasmids
pGU0303 (pGEM-T EasyΩcj0641), pGU0304 (pGEM-T
EasyΩcj0774c) and pGU0305 (pGEM-T EasyΩcj1663)
Table 1: Proteins found by sequence and domain searches of the genome C. jejuni strain NCTC 11168 using E. coli enzymes involved in 
phosphonate utilisation
E. coli Protein C. jejuni Protein/Function Sequence Similarity (%) Domain Homology
PhnH Cj0641/Unknown function. 24 -----------
PhnK Cj1663/Probable ATP-binding. 46 ABC_MJ0796
Cj0774c/Probable binding protein. 50 ABC_MJ0796
PhnL Cj1663/Probable ATP-binding. 49 ABC_MJ0796Gut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
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indicated that the amplified regions cj0641, cj0774c and
cj1663 from C. jejuni 81116, had a 96–99% nucleotide
sequence identity with the sequences of the correspond-
ing C. jejuni NCTC 11168 genes.
In vitro mutagenesis of Campylobacter jejuni genes
Disruption of cj0641 in plasmid pGU0303 and of cj0774c
in plasmid pGU0304 was performed by insertion of a
non-polar KmR cassette [18] within unique restriction sites
ClaI and HindIII, respectively. No unique restriction sites
existed in cj1663 which would serve to insert an antibiotic
cassette in this gene. Hence, inverse PCR of pGU0305 was
employed to generate BglII restriction sites for insertional
inactivation of cj1663. The primers cj1663p2A INV and
cj1663p2B INV were designed based on the nucleotide
sequence of cj1663  cloned into recombinant plasmid
pGU0305 (Table 1). Inverse PCR of pGU0305 generated
a linearised plasmid with BglII sites incorporated into the
primer termini, which was used to insert the KmR cassette
into cj1663. The insertion of the KmR cassette within each
gene was verified by restriction enzyme digest and
sequence analysis.
The recombinant plasmids with disrupted C. jejuni genes
pGU0306 (pGEM-T EasyΩcj0641ΩKmR), pGU0307
(pGEM-T EasyΩcj0774cΩKmR) and pGU0308 (pGEM-T
EasyΩcj1663ΩKmR) were subsequently employed to gen-
erate isogenic mutants of C. jejuni 81116.
Generation and identification of C. jejuni 81116 isogenic 
mutants
The disrupted cj0641, cj0774c and  cj1663  genes were
introduced into the genome of wild-type C. jejuni by elec-
troporating electro-competent C. jejuni 81116 cells with
plasmid DNA containing the mutated genes. Transformed
bacteria could only be recovered on primary isolation
plates.
To verify the presence of isogenic mutants, the transform-
ants were initially grown on a TSA/HBA recovery plates
without antibiotic selection. Subsequent plating onto
kanamycin selective media resulted in cell death. All
attempts to recover pure cultures of the isogenic mutants
were unsuccessful. PCR analyses of bacterial DNA from
single colonies on the initial recovery plates indicated that
the genes disrupted by the insertion of the KmR cassette
were present in the genome of some of the cells, showing
that the cultures which grew on the plates were a mixed
bacterial cell population. Verification of the insertion of
the kanamycin cassette was determined by amplification
of the KmR cassette. Amplicons of either mutant or wild-
type gene could not be recovered using the gene-specific
primers from mixed populations (Figure 1).
Since none of the isogenic mutants could be isolated but
grew in mixed cultures on primary recovery plates, it was
hypothesised that the mutants may require a product or
products produced by the wild-type strain to survive.
Mixed cultures of wild-type and mutant bacteria harvested
from primary isolation plates were grown in liquid "con-
ditioned media" with or without 50 μg/ml kanamycin. In
controls, mixed bacterial cultures were grown in liquid
fresh media with or without kanamycin. In the presence
of kanamycin C. jejuni 81116 cells grew only in condi-
tioned media (Table 3). The C. jejuni bacteria isolated
from cultures grown in conditioned media with kanamy-
cin were plated onto TSA/HBA plates with or without 50
μg/ml kanamycin, but no bacteria were recovered from
any these cultures, suggesting that bacteria without the
kanamycin cassette were screened out by the conditioned
media with kanamycin.
Measurement of phosphonate degradation by E. coli 
lysates
Degradation of PhePhn, phosphonoacetate (PhnAce),
AmePhn and PhePhi, was measured in whole-cell lysates
of wild-type E. coli DH5α grown on LBA plates. The catab-
olism of phosphonate was confirmed as resulting from
enzyme activities by heating the lysates for 4 h at 80°C, or
by suspending them in 1% SDS and observing the aboli-
tion of catabolic activity.
Degradation of PhePhn, PhnAce and AmePhn was meas-
ured in E. coli whole-cell lysates of bacteria transformed
with either of the plasmids pGEM-T Easy pGU0303,
pGU0304, pGU0305, pGU0306, pGU0307 or pGU0308
Table 2: Primers used to clone C. jejuni strain 81116 genes
Name Sequence
cj0641-F 5'-CTT TTG CTT TGC TAA GAT TTG AT
cj0641-R 5'-TAA TCA TCA ATT TCC CCA GTC
cj0774c-F 5'-CTT CAT TCA TGA TGC CAC CTC C
cj0774c-R 5'-TGA ACT TCA AAA TCT AAG AGG T
cj1663-F 5'-GTG TGT GAA AAT TTG AAA GGT G
cj1663-R 5'-TCA TTT TAA CAC CCC ATG TTG
cj1663p2A INV 5'-GAA GAT CTC CCA TTG TCT AAG ATA TAC TCC C
cj1663p2B INV 5'-GAA GAT CTC CAA TAC TAT CAC TCA TGG ACA TGut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
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(Figure 2). Similarly to untransformed wild-type bacteria,
the lysates of cells transformed with pGU0303, pGU0304
and pGU0305 showed degradation of PhePhn and
PhnAce, with significant reductions in the rates. AmePhn
degradation was similar in cells transformed with
pGU0303, pGU0304 and pGU0305 relative to the rates
measured in the control. Transformation of E. coli with
pGU0306, pGU0307 or pGU0308 had no effect on any of
the three activities. In addition, no change was observed
in the degradation of PhePhi between all strains
(Figure 2).
Discussion
Previous studies demonstrated that Campylobacter  spp.
catabolise various phoshonates [12], but sequence analy-
ses of the C. jejuni strains 11168 and RM1221 genomes
did not identify in this species orthologues of genes
involved in phosphonate degradation in E. coli or Salmo-
nella typhimurium. Nonetheless, the coding sequences
cj0641, cj0774c and  cj1663  showed some sequence or
domain homology to genes encoding proteins of the C-P
lyase of E. coli. These genes were disrupted in C. jejuni
strain 81116 to determine whether the resultant mutants
were altered in their ability to degrade phosphonates. The
low sequence similarity between E. coli PhnH, PhnK and
PhnL and C. jejuni proteins was in contrast with the high
sequence similarity found with Enterobacter sp. 638 and K.
pneumoniae proteins of the C-P lyase pathway, suggesting
that the C. jejuni enzymes belong to different pathways.
The three genes from C. jejuni strain 81116 were cloned,
and analyses of their sequences showed nucleotide identi-
ties of 96–99% with the cj0641, cj0774c and cj1663 genes
of C. jejuni strain 11168. The data indicated that the genes
were highly conserved, even more than the highly con-
served flaA genes of Campylobacter spp. which have simi-
Campylobacter jejuni single colonies from the initial isolation plate Figure 1
Campylobacter jejuni single colonies from the initial isolation plate. Lane 1: 1 kb ladder. Lane 2: pGU0303 amplified 
cj0641 using gene-specific primers. Lane 3: pGU0306 amplified KmR using KmR-specific primers. Lane 4: C. jejuni from the origi-
nal isolation plate, amplified cj0641 using gene-specific primers. Lane 5: C. jejuni from the original isolation plate, amplified KmR 
using KmRspecific primers. Lane 6–9: C. jejuni from the original isolation plate, using a combination of gene- and KmR-specific 
primers. Lane 10: KmR cassette.
1            2           3           4           5             6  7           8           9          10
Lane 1: 1Kb ladder
Lane 2: pGU0303 amplified cj0641 using gene-specific primers.
Lane 3: pGU0306  amplified KmR using KmR-specific primers.
Lane 4: C. jejuni mixed culture, amplified cj0641 using gene-specific primers.
Lane 5: C. jejuni mixed culture, amplified KmR using KmRspecific primers.
Lane 6-9: C. jejuni mixed culture, using a combination of gene- and KmR-specific primers.
Lane 10: KmR casette.Gut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
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Table 3: Growth rates of mixed cultures of C. jejuni strain 81116 wild-type and isogenic mutants in fresh and conditioned Brucella 
Broth with and without 50 μg/ml kanamycin. 
Growth media Bacterial growth (cfu/ml)
wild-type cj0641-+ wild-type cj0774c-+ wild-type cj1663-+ wild-type
Brucella Broth 7.0 × 109 6.0 × 109 6.5 × 109 7.0 × 109
Brucella Broth + Kanamycin ----- ----- ----- -----
Conditioned Brucella Broth 7.0 × 109 8.5 × 109 7.2 × 109 7.8 × 109
Conditioned Brucella Broth + Kanamycin ----- 2.0 × 108 2.0 × 108 4.4 × 108
Cell growth was determined by measuring absorbances at 410 nm and converting these data to cfu/ml using a calibration curve
Rates of degradation of four different substrates by E. coli strains Figure 2
Rates of degradation of four different substrates by E. coli strains. Measurements were performed at 37°C, using one-
dimensional 1H-NMR spectroscopy (n = 3). Control: wild-type; pGUO0303: mutant transformed with pGEM-T EasyΩcj0641; 
pGUO0304: mutant transformed with pGEM-T EasyΩcj0774c; pGUO0305: mutant transformed with pGEM-T EasyΩcj1663; 
pGU0306: mutant transformed with pGEM-T EasyΩcj0641ΩKmR; pGU0307: mutant transformed with pGEM-T 
EasyΩcj0774cΩKmR; and pGU0308: mutant transformed with pGEM-T EasyΩcj1663ΩKmR. The activities of the wild-type were 
considered 100% and mutant activities are presented relative to the total control activity for the specific substrate. Histogram 
patterns correspond to degradation rates of PhePhn: inclined lines; PhnAce: horizontal lines; AmePhn: dots; and PhePhi: empty. 
The errors were calculated by determining the standard deviation from the mean of triplicate experiments.
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larities between 73.6 and 92.3% [19]. The three genes
were not co-located or co-transcribed in the C. jejuni
11168 or 81116 genomes, and did not form part of oper-
ons.
The genes cj0641, cj0774c or cj1663 were inactivated by
inserting a KmR cassette, and C. jejuni 81116 isogenic
mutants were constructed by incorporation of each the
disrupted genes into the genome of the wild-type strain
through double allelic exchanges. The mutant bacteria
were not viable, but were able to grow in mixed cultures
with the wild-type strain. Growth experiments suggested
that the mutants required for viability some factor(s)
expressed by the wild-type strain. It is highly unlikely that
a mutation in each of the three genes would result in iden-
tical phenotypes by chance. Inactivation of these genes by
insertion of a KmR cassette may have resulted in polar
mutations. However, none of three genes belongs to a rec-
ognisable cluster or to an operon, and analyses of the
genes downstream of cj0641, cj0774c and  cj1663  indi-
cated that they were not co-transcribed. In addition, the
insertion of the KmR  cassette has been performed in
numerous studies without having polar effects on down-
stream genes [18,20]. Thus, polar mutations probably
were not the cause of the decreased survival. Alternatively,
it is possible that these genes encode multifunctional pro-
teins given that the C. jejuni genome is one of the most
densely transcribed genomes known to date [17], and
some of the functions of those proteins could be essential
to the survival of C. jejuni.
The results of the bacterial cell culture experiments indi-
cated the dependence of mutated C. jejuni on the wild-
type strain for survival, suggesting that the mutants lacked
the ability to produce, regulate, or utilise some com-
pound(s) produced by the wild-type C. jejuni strain
81116.
Indirect evidence for the involvement of the proteins
CJ0641, CJ0774c and CJ1663 in phosphonate degrada-
tion was obtained by expressing them in E. coli DH5α
transformed with plasmids carrying each one of the genes.
The C-P lyase enzyme of E. coli is expressed under condi-
tions of phosphate starvation [6]. To ensure that this
endogenous E. coli lyase was not expressed, bacteria were
grown in the presence of inorganic phosphate. Hence, the
catabolism of phosphonates observed in the transformed
E. coli was the result of other enzyme activities (Figure 2).
Transformation of the wild-type E. coli strain with the
plasmid pGEM-T Easy did not affect the rates of degrada-
tion of PhePhn, PhnAce and AmePhn. Transformation
with a plasmid bearing cj0641, cj0774c or cj1663 altered
the rate of PhePhn and PhnAce degradation relative to the
wild-type (Figure 2). Transformation with a plasmid bear-
ing one of the three genes inactivated with a kanamycin
cassette had no effect on phosphonate degradation (Fig-
ure 2). The largest inhibition of PhePhn degradation was
observed in E. coli transformed with cj0641, while the larg-
est inhibition of PhnAce was due to transformation with
cj1663. The relative decrease of phosphonate degradation
between the three strains suggested that CJ0641 was more
specific to PhePhn and CJ1663 was more specific to
PhnAce. Comparison of the relative decrease of phospho-
nate degradation between substrates for each strain
showed that E. coli transformed with pGU0303 and
pGU0304 decreased PhnAce and PhePhn catabolism in
equal amounts, while pGU0305 inhibited PhnAce degra-
dation significantly more than that of PhePhn.
A reasonable expectation for the expression of an exoge-
nous enzyme in a bacterium which also has a similar
endogenous activity is that the overall activity measured
in the transformed bacterium will be higher than in the
parent organism. However, the measured activity is mod-
ulated by a number of factors including the relative abun-
dance of both enzymes, their affinity for the substrate,
their velocities and the substrate concentration. Regarding
the latter, the overall measured activity will be higher
when the concentration of the substrate is sufficient for
both the endogenous and exogenous enzymes to operate
as if the other were not present. Otherwise, both enzymes
Table 4: Bacterial strains and plasmids used in the study
Bacterial Strain or Plasmid Origin and phenotype/Plasmid description
C. jejuni 11168 Human origin. Serotype O2. [22]
C. jejuni 81116 Human origin, motile isolate. [23]
E. coli DH5α SupE44ΩlacU169 (80lacZΩM15) hsdR17 recA1 endA1 gyrA96 thi-1 rel-A1 [21]
pGU0303 pGEM-T EasyΩcj0641 (This study)
pGU0304 pGEM-T EasyΩcj0774c (This study)
pGU0305 pGEM-T EasyΩcj1663 (This study)
pGU0306 pGEM-T EasyΩcj0641ΩKmR (This study)
pGU0307 pGEM-T EasyΩcj0774cΩKmR (This study)
pGU0308 pGEM-T EasyΩcj1663ΩKmR (This study)Gut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
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will compete for the substrate and depending on their rel-
ative affinities for the substrate and velocities, the overall
measured activity may be higher, not significantly
changed or lower. The latter case could occur when the
exogenous enzyme has a much greater affinity and signif-
icantly lower velocity. In the case of PhePhn and PhnAce
the substrate concentrations are well below saturation of
the C. jejuni enzymes [12], hence the enzymes expressed
in E. coli will compete with the endogenous activities, and
the observed decrease of overall rates in the transformed
bacteria could be explained by a competition of enzymes
for the substrate
Several factors could be responsible for the lack of change
in the rates of AmePhn degradation. C. jejuni has an
enzyme system that degrades PhePhn and PhnAce and an
independent system that degrades AmePhn, with the
catabolism of AmePhn approximately half of that of the
other two phosphonates [12]. This suggested that the
former activities were due to different enzyme(s) than that
of the latter. Also, the absence of changes in the rates of
AmePhn degradation may be due to homologues of the
broad specificity C-P lyase of E. coli [8] having different
specificities in C. jejuni. Finally, the rate of AmePhn degra-
dation may have undergone changes which were below
the levels of detection owing to its significantly smaller
value than the rate of PhePhn and PhnAce.
No change was observed in the degradation of PhePhi
between all strains showing that the changes in activity are
specific to phosphonate degradation, thus, supporting the
interpretation that these genes are involved in phospho-
nate metabolism.
Conclusion
The data showed that the gene products of cj0641, cj0774c
and cj1663 were essential for the survival of the bacte-
rium. In addition, evidence supported that CJ0641,
CJ0774c and CJ1663 would be involved in phosphonate
metabolism in the bacterium. The specific molecular
events leading to changes in phosphonate degradation in
transformed E. coli remain to be fully elucidated, but the
study demonstrated that the C. jejuni proteins expressed
in E. coli modulated the rates of phosphonate catabolism
in the latter.
Methods
Materials
Brain Heart Infusion (BHI) Broth, Brucella Broth, Colum-
bia Agar, Luria Broth, Tryptone Soya Agar (TSA) and defi-
brinated horse blood were from Oxoid (Heilderberg, VIC,
Australia). Ampicillin and kanamycin, were purchased
from Sigma (St Louis, MO, USA); and isopropyl-β-D-1-
thioglactopyranoside (IPTG) and 5-bromo-4-chloro-3-
indolyl-β-D-galactoside (X-Gal) were from Progen Bio-
sciences (Archefield, QLD, Australia). Phosphonoacetic
acid (PhnAce), α-aminomethylphosphonic acid
(AmePhn), phenylphosphonic acid (PhePhn), and phe-
nylphosphinic acid (PhePhi) were from Aldrich (Milwau-
kee, WI, USA). Sodium dodecyl sulfate (SDS) was from
Amresco (Solon, OH, USA). All other reagents were of
analytical grade.
Bacterial strains, plasmids and growth conditions
The C. jejuni and E. coli strains, and the plasmids [21] used
in this study are listed in Table 4. Campylobacter jejuni
strains NCTC 11168 [22] and 81116 [23] were grown on
Columbia Agar supplemented with 5% (v/v) defibrinated
horse blood (HBA), or TSA supplemented with 5% (v/v)
defibrinated horse blood and ampicillin or kanamycin
when required. C. jejuni cells were incubated for 48 hours
at 37°C under the microaerobic conditions 90% N2, 5%
CO2, and 5% O2. Liquid cultures of C. jejuni were grown
in Brucella Broth, at 37°C for 24–48 hours under the
same microaerobic conditions as for plates. Cell growth
was determined by measuring optical densities (OD) at
410 nm.
"Conditioned" Brucella Broth to grow mutant C. jejuni
bacteria was prepared by growing wild-type C. jejuni strain
81116 in Brucella Broth for 24 hours, removing the cells
by centrifugation, and collecting and filtering the superna-
tant. The absence of viable cells in the supernatant was
verified by plating it and observing no growth on the
plates.
Escherichia coli strain DH5α was grown on Luria Broth
Agar (LBA) plates supplemented with ampicillin, kan-
amycin, IPTG or X-Gal when required, and incubated at
37°C for 24 hours. Liquid cultures of E. coli were grown in
Luria Broth with antibiotic supplements, ampicillin or
kanamycin, where necessary, and under the same condi-
tions as for plates.
Genome searches
Sequences of E. coli K12 proteins [24] were employed to
search in the fully annotated genomes of C. jejuni strains
NCTC 11168 and RM1221, as well as the genomes of
Klebsiella pneumoniae and Enterobacter sp. 638 for genes
orthologous to those involved in C-P bond hydrolysis.
The E. coli sequences were those encoded by the genes
phnG, phnH, phnI, phnJ, phnK, phnL, and phnM (accession
numbers P16685, P16686, P16687, P16688, P16678,
P16679, and P16689) that are required for alkylphospho-
nate catalysis and likely constituting a membrane-associ-
ated carbon-phosphorus (C-P) lyase [2,7].
Sequence homology searches were performed using the
BLASTP program for microbial genomes http://
www.ncbi.nlm.nih.gov/sutils/genom_table.cgi? of theGut Pathogens 2009, 1:13 http://www.gutpathogens.com/content/1/1/13
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National Center for Biotechnology Information (NCBI;
Bethesda, MD, USA). Domain homology searches were
carried out using the Conserved Domain Architecture
Retrieval Tool (CDART) of NCBI http://
www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?.
PCR amplifications
Primers for the genes cj0641, cj0774c and cj1663 in C.
jejuni strain 81116, were designed using the published
nucleotide sequence of C. jejuni strain NCTC 11168 [17].
Primer sequences are shown in Table 2. Protein similarity
analyses comparing the sequenced genes of C. jejuni
81116 to the published sequences of C. jejuni 11168 were
performed using BLASTP program for microbial genomes
of the NCBI.
Standard PCR in 50 μl reaction mixtures were performed
with the following parameters: 95°C for 4 minutes, 30
cycles of 94°C for 30 s, 52°C for 30 s, and 72°C for 2 min.
Template DNA was prepared by the crude lysis boiling
method, in which a single C. jejuni colony was boiled for
5 min in 150 μl of water and cellular debris were removed
by centrifugation.
Cloning and screening of recombinant plasmids pGU0303, 
pGU0304 and pGU0305
Amplified PCR fragments were cloned into the bacterial
cloning vector system pGEM-T Easy (Promega; Madison,
WI, USA) in E. coli by standard cloning techniques [25].
The plasmids pGU0303, pGU0304 and pGU0305 each
containing one of the three C. jejuni genes are described in
Table 4. Transformant colonies putatively carrying recom-
binant plasmids were screened by blue/white colony
selection, and further verified by PCR, using plasmid spe-
cific primers for the T7 and SP6 polymerase promoters,
which flank the multiple cloning region of pGEM-T Easy.
Prior to mutagenesis, constructs were sequenced by di-
dioxynucleotide sequencing, to verify the correct base pair
order.
In vitro mutagenesis of cloned Campylobacter jejuni
genes cj0641, cj0774c and cj1663 Mutagenesis was per-
formed by insertional inactivation of the genes cj0641,
cj0774c and cj1663 using a non-polar kanamycin antibi-
otic resistance cassette KmR [26,27]. The KmR cassette was
amplified from the plasmid pMW2 using primers with
BglII sites incorporated into the termini (Table 2). The
KmR cassette was inserted into unique restriction sites
within the cloned C. jejuni inserts. Linearised plasmids for
pGU0303 (pGEM-T EasyΩcj0641), and pGU0304
(pGEM-T EasyΩcj0774c) were generated by restriction
enzyme digestion with ClaI and HindIII respectively,
according to the manufacturer's instructions.
The plasmid pGU0305 (pGEM-T EasyΩcj1663) was line-
arised by inverse PCR, as no unique restriction sites
existed within cj1663. The primers cj1663p2A INV and
cj1663p2B INV were designed based on the nucleotide
sequence of pGU0305 and created a small deletion within
cj1663. Inverse PCR in 50 μL reaction mixtures was con-
ducted as follows: 95°C for 5 min, 40 cycles 94°C for 30
s, 52°C for 1 min, and 72°C for 5 min. The Eppendorf Tri-
pleMaster Taq was the DNA polymerase used for inverse
PCR (Eppendorf; North Ryde, NSW, Australia).
Campylobacter jejuni isogenic mutants
Electrocompetent C. jejuni strain 81116 cells were pre-
pared [28] and transformed with mutated recombinant
plasmids using a BioRad MicroPulser (BioRad; Regents
Park, NSW, Australia) at a voltage of 2.48 V, and time con-
stant of 5 min. The contents of the 2 mm cuvettes were
flushed with BHI broth and allowed to recover at 37°C for
5 h under microaerobic conditions. Reactions were plated
onto TSA/HBA plates.
Measurement of phosphonate catabolism using nuclear 
magnetic resonance spectroscopy
Wild-type and transformed E. coli strain DH5α cells were
grown on LBA plates supplemented with 50 μg/ml ampi-
cillin and incubated at 37°C for 6 h. The bacteria were
harvested in 150 mM sodium chloride (NaCl) and centri-
fuged 16,000 × g at 4°C for 10 min. The pellet was col-
lected and the supernatant discarded. The pellet was
resuspended in 14 ml 150 mM NaCl solution and washed
twice more. Cells were lysed by twice freezing in liquid
nitrogen and thawing.
Catabolism of AmePhn, PhePhn, PhePhi and PhnAce was
measured employing proton nuclear magnetic resonance
(1H-NMR) spectroscopy. Lysates (150 μl) were suspended
in 150 mM NaCl and mixed with 2H2O (50 μl), 150 mM
KCl (50 μl), and 150 mM NaCl (150 μl) before phospho-
nate was added at time zero to give a final volume of 600
μl. Initial concentrations of phosphonate substrates were
120 mM. Suspensions of bacterial lysates were placed in 5
mm NMR tubes (Wilmad; Buena, NJ, USA) and measure-
ments of enzyme activities were carried out at 37°C. 1H-
NMR free induction decays were collected using a Bruker
DMX-600 spectrometer, operating in the pulsed Fourier
transform mode with quadrature detection. The instru-
mental parameters for the spectrometer were: operating
frequency 600.13 MHz, spectral width 6009.61 Hz, mem-
ory size 16 K, acquisition time 3.61 s, number of tran-
sients 64, pulse angle 50° (ca. 3 μs) and relaxation delay
with solvent presaturation 1.7 s. Spectral resolution was
enhanced by Gaussian multiplication with line broaden-
ing of 0.7 Hz and Gaussian broadening factor of 0.19.
Proton spectra were acquired with presaturation of the
water resonance. The time-evolution of substrates and
products were followed by acquiring sequential spectra of
the reactions. Enzyme rates were obtained by measuring
the decrease over time of the intensity of resonances aris-Publish with BioMed Central    and   every 
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ing from the phosphonate compounds. Calibrations of
substrate peaks were performed by extrapolating the reso-
nance intensity data to zero time and assigning to this
intensity the original concentration value.
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